Compounders Research Compare

PMGC Holdings Inc.(ELAB)

Biotechnology · Newport Beach, CA

$3.30+0.03 (+0.92%)

Delayed quote: Oct 6, 2026, 3:42 PM EDT

About PMGC Holdings Inc.

PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.

Newport Beach, CA

33 employees

pmgcholdings.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Graydon Bensler

View full financials

PMGC Holdings (ELAB) Price/FCF Ratio: History & Chart | TGMCharts

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T19:47:02.328Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:47:02.328Z.

Quote observation: 2026-10-06T19:42:03.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,499,438
TTM free cash flow · period ending 2026-06-30: N/A

FMP input reference: ec04a23f2eccb1c46d806cafb3c6508f31619b4012dc27c85b71ebd533873098

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ELAB Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

ELAB Competitors' Price/FCF Ratio

PMGC Holdings Inc.

Current

Market Cap

$1.50M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Curis, Inc.

Market Cap

$1.44M

Price/FCF Ratio

N/A

TTM Avg

58.11

3Y Avg

58.11

5Y Avg

58.11

Lakewood-Amedex Biotherapeutics, Inc.

Market Cap

$1.50M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEXGEL, Inc.

Market Cap

$1.45M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INVO Fertility, Inc.

Market Cap

$1.42M

Price/FCF Ratio

N/A

TTM Avg

8.14

3Y Avg

8.14

5Y Avg

8.14

Jupiter Neurosciences, Inc.

Market Cap

$1.35M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NewcelX Ltd.

Market Cap

$1.33M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Genprex, Inc.

Market Cap

$1.32M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Artelo Biosciences, Inc.

Market Cap

$1.32M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Silo Pharma, Inc.

Market Cap

$1.60M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
PMGC Holdings Inc. (ELAB)	$1.50M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.44M	N/A	58.11	58.11	58.11
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.50M	N/A	N/A	N/A	N/A
NEXGEL, Inc. (NXGL)vs ›	$1.45M	N/A	N/A	N/A	N/A
INVO Fertility, Inc. (IVF)vs ›	$1.42M	N/A	8.14	8.14	8.14
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.35M	N/A	N/A	N/A	N/A
NewcelX Ltd. (NCEL)vs ›	$1.33M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.32M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.32M	N/A	N/A	N/A	N/A
Silo Pharma, Inc. (SILO)vs ›	$1.60M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Growth Operating Margin All Metrics